Annual Cash & Cash Equivalents
$191.44 M
+$77.89 M+68.59%
December 31, 2023
Summary
- As of February 7, 2025, STOK annual cash & cash equivalents is $191.44 million, with the most recent change of +$77.89 million (+68.59%) on December 31, 2023.
- During the last 3 years, STOK annual cash & cash equivalents has fallen by -$95.87 million (-33.37%).
- STOK annual cash & cash equivalents is now -33.37% below its all-time high of $287.31 million, reached on December 31, 2020.
Performance
STOK Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$150.02 M
-$43.46 M-22.46%
September 30, 2024
Summary
- As of February 7, 2025, STOK quarterly cash and cash equivalents is $150.02 million, with the most recent change of -$43.46 million (-22.46%) on September 30, 2024.
- Over the past year, STOK quarterly cash and cash equivalents has dropped by -$39.96 million (-21.03%).
- STOK quarterly cash and cash equivalents is now -47.79% below its all-time high of $287.31 million, reached on December 31, 2020.
Performance
STOK Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
STOK Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +68.6% | -21.0% |
| 3 y3 years | -33.4% | -21.0% |
| 5 y5 years | +81.6% | -21.0% |
STOK Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.6% | -22.5% | +121.4% |
| 5 y | 5-year | -33.4% | +68.6% | -47.8% | +121.4% |
| alltime | all time | -33.4% | >+9999.0% | -47.8% | +121.4% |
Stoke Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $150.02 M(-22.5%) |
| Jun 2024 | - | $193.48 M(+8.3%) |
| Mar 2024 | - | $178.58 M(-6.7%) |
| Dec 2023 | $191.44 M(+68.6%) | $191.44 M(+0.8%) |
| Sep 2023 | - | $189.98 M(-1.1%) |
| Jun 2023 | - | $192.06 M(+0.9%) |
| Mar 2023 | - | $190.34 M(+67.6%) |
| Dec 2022 | $113.56 M(-21.6%) | $113.56 M(+0.1%) |
| Sep 2022 | - | $113.40 M(+67.4%) |
| Jun 2022 | - | $67.75 M(-19.4%) |
| Mar 2022 | - | $84.11 M(-42.0%) |
| Dec 2021 | $144.90 M | $144.90 M(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $149.04 M(-11.8%) |
| Jun 2021 | - | $169.07 M(-36.8%) |
| Mar 2021 | - | $267.51 M(-6.9%) |
| Dec 2020 | $287.31 M(+29.1%) | $287.31 M(+50.1%) |
| Sep 2020 | - | $191.46 M(-5.2%) |
| Jun 2020 | - | $201.93 M(-4.4%) |
| Mar 2020 | - | $211.29 M(-5.0%) |
| Dec 2019 | $222.47 M(+111.1%) | $222.47 M(-4.5%) |
| Sep 2019 | - | $233.05 M(-4.0%) |
| Jun 2019 | - | $242.68 M(+146.0%) |
| Mar 2019 | - | $98.65 M(-6.4%) |
| Dec 2018 | $105.40 M(+5765.3%) | $105.40 M |
| Dec 2017 | $1.80 M | - |
FAQ
- What is Stoke Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Stoke Therapeutics?
- What is Stoke Therapeutics annual cash & cash equivalents year-on-year change?
- What is Stoke Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Stoke Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of STOK is $191.44 M
What is the all time high annual cash & cash equivalents for Stoke Therapeutics?
Stoke Therapeutics all-time high annual cash & cash equivalents is $287.31 M
What is Stoke Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, STOK annual cash & cash equivalents has changed by +$77.89 M (+68.59%)
What is Stoke Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of STOK is $150.02 M
What is the all time high quarterly cash and cash equivalents for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly cash and cash equivalents is $287.31 M
What is Stoke Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, STOK quarterly cash and cash equivalents has changed by -$39.96 M (-21.03%)